Detailed description page of B3Pdb
This page provides detail information of Selected ID b3pdb_0049 |
Primary information | |
---|---|
B3PDB ID | b3pdb_0049 |
Peptide Name | gH625Cys |
PEPTIDE SEQUENCE (1-letter) | HGLASTLTRWAHYNALIRAF |
PEPTIDE SEQUENCE (3-letter) | HisGlyLeuAlaSerThrLeuThrArgTrpAlaHisTyrAsnAlaLeuIleArgAlaPhe |
N-terminal modification | Acetylaed at N-terminal |
C-terminal modification | Cys-CONH2 group is attached at C-terminal |
Chemical modification | NA |
Peptide Length | 21 |
Conformation | Linear |
Peptide Nature | NA |
Source/Origin of peptide | Chemically synthesized |
SMILES | N[C@@]([H])(CC1=CN=C-N1)C(=O)NCC(=O)N[C@@]([H])(CC(C)C)C(=O)N[C@@]([H])(C)C(=O)N[C@@]([H])(CO)C(=O)N[C@@]([H])([C@]([H])(O)C)C(=O)N[C@@]([H])(CC(C)C)C(=O)N[C@@]([H])([C@]([H])(O)C)C(=O)N[C@@]([H])(CCCNC(=N)N)C(=O)N[C@@]([H])(CC(=CN2)C1=C2C=CC=C1)C(=O)N[C@@]([H])(C)C(=O)N[C@@]([H])(CC1=CN=C-N1)C(=O)N[C@@]([H])(Cc1ccc(O)cc1)C(=O)N[C@@]([H])(CC(=O)N)C(=O)N[C@@]([H])(C)C(=O)N[C@@]([H])(CC(C)C)C(=O)N[C@@]([H])([C@]([H])(CC)C)C(=O)N[C@@]([H])(CCCNC(=N)N)C(=O)N[C@@]([H])(C)C(=O)N[C@@]([H])(Cc1ccccc1)C(=O)O |
Cell Line | BMECs |
In vitro CONCENTRATION | 5 micromolar |
In vitro METHOD | Fluorescence microscopy |
In vitro RESULT | Liposomes preparations were non-toxic for the endothelial cells and improves the transfer of liposom |
ANIMAL MODEL | Mouse |
In vivo CONCENTRATION | NA |
In vivo MODE OF DELIVERY | Intravenous |
In vivo METHOD | Fluorescence microscopy |
In vivo RESULT | gH625 ameliorates the efficiency of liposomes to deliver. PACAP |
ACTION | gH625-liposomes represent a promising strategy to deliver therapeutic agents to CNS and to provide a |
TRANSPORT TYPE | NA |
SUBCELLULAR LOCALISATION | NA |
COMBINATION | Comined with liposome |
PHYSICAL CONDITION | NA |
RESPONSE | NA |
RESULT | NA |
LABEL | NA |
PMID | 31235716 |